Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Insys executive gave doctor lap dance while promoting drug, witness says

Published 01/29/2019, 06:44 PM
Updated 01/29/2019, 06:44 PM
© Reuters. Sunrise Lee, a former Insys Therapeutics Inc regional sales director, exits the federal courthouse in Boston

By Nate Raymond

BOSTON (Reuters) - An ex-stripper who became a regional sales director at Insys Therapeutics Inc gave a doctor a lap dance at a Chicago club as the drugmaker pushed the doctor to prescribe its addictive fentanyl spray, a former Insys employee testified on Tuesday.

The testimony in federal court in Boston came in the first criminal trial of painkiller manufacturer executives over conduct that authorities say contributed to a U.S. opioid abuse epidemic that has killed tens of thousands of people a year.

Former Insys sales representative Holly Brown told jurors the incident with her boss, Sunrise Lee, took place after Insys began rewarding the doctor for prescribing its opioid product by paying him to speak at educational events about the drug.

That Illinois doctor, Paul Madison, is one of several whom prosecutors say Lee and four other former Insys executives and managers including wealthy founder and ex-chairman John Kapoor conspired to bribe to boost sales of the spray, Subsys.

Lee, Kapoor, Michael Gurry, Richard Simon and Joseph Rowan deny wrongdoing and have pleaded not guilty to racketeering conspiracy.

The U.S. Food and Drug Administration has only approved Subsys for treating cancer pain. Prosecutors allege doctors paid by Insys often prescribed Subsys to patients without cancer. Defense lawyers note, though, that doctors may prescribe medications for off-label purposes.

Drugmakers often retain doctors to speak at events with other clinicians about the benefits of their drugs, and defense lawyers argue the events were legal compensation for the doctors' educational work.

Yet Brown said Madison's events, held at a Chicago restaurant Kapoor owned, were attended by his friends instead of clinicians.

"The idea was these weren't really meant to be educational programs but were meant to be rewards to physicians," Brown said.

After one dinner in mid-2012, Brown said she, Lee and Madison went to a club, where she witnessed Lee "sitting on his lap, kind of bouncing around."

"He had his hands sort of inappropriately all over her chest," Brown said.

Brown testified that at the time, Madison ran a "notorious" medical practice, which in a 2012 email shown to jurors she described as a "shady pill mill."

Prosecutors say Insys paid Madison at least $70,800 in speaker fees.

Asked on cross-examination by Lee's attorney, Peter Horstmann, if Madison "appeared to be taking advantage of Ms. Lee," Brown said yes.

© Reuters. Sunrise Lee, a former Insys Therapeutics Inc regional sales director, exits the federal courthouse in Boston

Madison was convicted in November of unrelated charges that he defrauded insurers into paying for unperformed chiropractic procedures. His lawyer did not respond to requests for comment.

Latest comments

Gotta make that paper some how.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.